Shin Nippon Biomedical Laboratories, Ltd. (TYO:2395)
1,299.00
+20.00 (1.56%)
Jul 21, 2026, 1:43 PM JST
TYO:2395 Stock Forecast
Stock Price Forecast
According to 2 analysts polled by S&P Global, TYO:2395 stock has a consensus rating of "Buy" and an average price target of ¥1,640. The average 1-year stock price forecast is 26.25% higher than the current stock price, while the lowest is ¥1,280 (-1.46%) and the highest is ¥2,000 (+53.96%).
Price Target: ¥1,640 (+26.25%)
Analyst Consensus: Buy
Price Target
Chart* Price targets were last updated on Jun 1, 2026.
Analyst Ratings
The average analyst rating for TYO:2395 stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Nov '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 1 | 1 | 1 | 1 | 1 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
Unknown Analyst Nomura No rating | Nomura | Hold Downgrades ¥2,090 → ¥1,280 | Hold | Downgrades | ¥2,090 → ¥1,280 | -1.46% | Jun 1, 2026 |
Unknown Analyst Tokai-Tokyo Securities No rating | Tokai-Tokyo Securities | Buy Maintains ¥2,000 | Buy | Maintains | ¥2,000 | +53.96% | May 26, 2026 |
Financial Forecast
Revenue This Year
38.37B
from 32.52B
Increased by 17.98%
Revenue Next Year
40.96B
from 38.37B
Increased by 6.75%
EPS This Year
n/a
EPS Next Year
n/a
Financial currency is JPY.